The Verge questions whether Abbott's device can escape typical wearable hype.
The Verge posted about Abbott's upcoming 2-in-1 continuous glucose monitor designed to track both glucose and ketone levels for diabetics. The column notes that such monitors are growing more complex and likens their evolution to Pokemon. It raises the question of whether the new device can sidestep the usual wearable hype cycle. The post points readers to the full column on the publication's site for further details on the technology and its potential uses in managing diabetic ketoacidosis risks. No other sources appear in the packet to confirm additional aspects of the announcement.
27K
1 post, first seen 5d ago
The Verge questions whether Abbott's device can escape typical wearable hype.
The Verge posted about Abbott's upcoming 2-in-1 continuous glucose monitor designed to track both glucose and ketone levels for diabetics. The column notes that such monitors are growing more complex and likens their evolution to Pokemon. It raises the question of whether the new device can sidestep the usual wearable hype cycle. The post points readers to the full column on the publication's site for further details on the technology and its potential uses in managing diabetic ketoacidosis risks. No other sources appear in the packet to confirm additional aspects of the announcement.
The Verge@vergeAbbott’s new 2-in-1 CGM will help diabetics monitor ketone levels. But can it avoid the wearable hype cycle?
The Verge@vergeAbbott’s new 2-in-1 CGM will help diabetics monitor ketone levels. But can it avoid the wearable hype cycle?
